![](/img/cover-not-exists.png)
A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial
Saridaki, Z, Androulakis, N, Vardakis, N, Vamvakas, L, Kabouraki, E, Kalbakis, K, Hatzidaki, D, Voutsina, A, Mavroudis, D, Georgoulias, V, Souglakos, JVolume:
107
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.509
Date:
December, 2012
File:
PDF, 242 KB
english, 2012